Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma
暂无分享,去创建一个
M. Heller | P. Bode | A. Uldry | J. Rössler | M. Bernasconi | Dzhangar Dzhumashev | Rita Sala | A. Timpanaro | Caroline Piccand | Michele Bernasconi